eegCap Application in Paediatrics wiTh redUced GCS in REsus

Learn more about:
Related Clinical Trial
Patient-reported Outcome After Status Epilepticus Point-of-care EEG in the Pediatric Emergency Department eegCap Application in Paediatrics wiTh redUced GCS in REsus Mainz Epilepsy Registry Assessment of Adults Epidemiological Characteristics of Status Epilepticus in the French West Indies and in French Guiana Repeated TMS at Low Frequencies to Reduce Seizure Occurrence VIGAB-BIOSTAT: Neuronal Injury Panel Substudy Effectiveness of Combined Levetiracetam and Midazolam in Generalized Convulsive Status Epilepticus in Children Comparison of Efficacy of Phenytoin With Levetireacetam for the Management of Children With Status Epilepticus Tracheostomy With Bedside Simultaneous Gastrostomy Vs Usual Care Tracheostomy And Delayed Gastrostomy Placement Phase 1, Open-label, Comparison Study of a Single IM Dose of Midazolam Using an Auto-injector vs a Marketed Midazolam Vial in Healthy Adults COVID-19 Brain Injury RAndomized Therapy In Status Epilepticus Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment Assessment of Severity and Prognosis for Patients With Status Epileptics(SE) Simulation RCT of Telemedical Support for Paramedics Seizure Rescue Medication: Caregiver Education in a Simulation Setting EEG in In-hospital Patients With Seizure or Altered Mental State Smartphone Apps for Pediatric Resuscitation Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children. Putting Electroencephalography (EEG) in the Emergency Department Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2) LORA-PITA IV General Investigation Creation, Implementation, and Analysis of a Seizure Action Plan Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus Lorazepam for the Treatment of Status Epilepticus in Children Diagnostic Value of Prehospital EEG in Non-convulsive Status Epilepticus TELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus Ketogenic Diet for Refractory Status Epilepticus Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus Improving Emergency Management of Status Epilepticus A Clinical Study of Children With Status Epilepticus in China Prognosis Factors Associated With Convulsive Status Epilepticus in Adults Management of Non Convulsive Status Epilepticus EEG Monitoring for Refractory Status Epilepticus SURESTEP: Transcranial Direct Current Stimulation in Super Refractory Status Epilepticus Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus Treatment of Refractory Status Epilepticus Status Epilepticus in the Critically Ill Patients Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures Ketamine in Refractory Convulsive Status Epilepticus Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan

Brief Title

eegCap Application in Paediatrics wiTh redUced GCS in REsus

Official Title

CAPTURE:eegCap Application in Paediatrics wiTh redUced GCS in REsus

Brief Summary

      Children frequently present with altered or reduced consciousness levels to emergency
      departments. By using EEG monitoring, subclinical seizure activity may be detected, leading
      to earlier pharmacological intervention and improved outcomes. Post-ictal phases that may be
      interpreted as seizure activity may become less over-treated. A feasibility study will
      ascertain if EEG monitoring can be applied successfully in this cohort, within a specified
      time period, obtaining minimum artefact (defined as < 25% artefact). EEG recordings will not
      be used to guide clinical management during this feasibility study.

Detailed Description

      See study protocol attached

Study Type


Primary Outcome

The percentage of children who had EEG monitoring applied within twenty minutes and obtainment of an interpretable EEG recording with less than 25% artefact.


Status Epilepticus


* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Estimated Enrollment


Start Date

July 5, 2021

Completion Date

December 2022

Primary Completion Date

July 2022

Eligibility Criteria

        Inclusion Criteria:

        Children between 0 and 15 years and 11 months who present to Resuscitation Room, ED, CUH
        with a Glasgow Coma Scale (GCS) < 11 or, a reduction in baseline GCS in the case of
        children with significant neurodisability at baseline

        Exclusion Criteria:

          -  Polytrauma

          -  Open head wounds

          -  Unstable airway or requirement for bag and mask ventilation, where cap application
             would affect clinical management




0 Months - 176 Months


Deirdre Murray, +35321 4205065, [email protected]

Location Countries


Location Countries


Administrative Informations



Organization ID


Responsible Party

Principal Investigator

Study Sponsor

University College Cork

Study Sponsor

Deirdre Murray, Principal Investigator, UCC and INFANT Centre

Verification Date

February 2022